title: IP_Bleo_AlveolarMacrophages_hto_rep2
organism: Mus musculus
attributes.tag: source_name
attributes.value: AM_aN2_HTO_Bleo
attributes.tag: protocol
attributes.value: Adult mice (older than 12 weeks) were randomized based on their weights before the study to minimize variance between experimental and control groups. Mice were treated with a blocking anti-Notch2-antibody or control (both 20 mg/mkg, ip) at days -14 and -7. and bleomycin was administered via Oropharyngeal intratracheal (IT) dosing on days 0, 2, and 4 at 0.24 U/kg (DNC 0703-3155-01; TEVA). Mice were taked down on day 9.
attributes.tag: tissue
attributes.value: lung_bleo
attributes.tag: cell type
attributes.value: Alveolar Macrophages
attributes.tag: genotype
attributes.value: WT_C57BL6/J
attributes.tag: treatment
attributes.value: mixed (ctrl, aNotch2)
attributes.tag: library type
attributes.value: HTO
attributes.tag: hto
attributes.value: TotalSeq™-C0301 anti-mouse Hashtag 1 Antibody, up until, TotalSeq™-C0310 anti-mouse Hashtag 10 Antibody
attributes.tag: geo_loc_name
attributes.value: missing
attributes.tag: collection_date
attributes.value: missing